John H. Malfetano

Randomized Comparison of Fluorouracil Plus Cisplatin Versus Hydroxyurea as an Adjunct to Radiation Therapy in Stage IIB-IVA Carcinoma of the Cervix With Negative Para-Aortic Lymph Nodes: A Gynecologic Oncology Group and Southwest Oncology Group Study

Charles W. Whitney, William T. Sause, Brian N. Bundy et al. · Journal of Clinical Oncology · 1999 · 1.5K citations · Full text

Topotecan versus paclitaxel for the treatment of recurrent epithelial ovarian cancer.

W ten Bokkel Huinink, Martin Gore, J Carmichael et al. · Journal of Clinical Oncology · 1997 · 681 citations

Phase III Trial of Doxorubicin With or Without Cisplatin in Advanced Endometrial Carcinoma: A Gynecologic Oncology Group Study

J.T. Thigpen, Mark F. Brady, Howard D. Homesley et al. · Journal of Clinical Oncology · 2004 · 382 citations

Combined analysis of studies of the effects of the matrix metalloproteinase inhibitor marimastat on serum tumor markers in advanced cancer: selection of a biologically active and tolerable dose for longer-term studies.

John Nemunaitis, C. J. Poole, John Primrose et al. · PubMed · 1998 · 213 citations

Pathology, Metronomic Chemotherapy, Tumor Biology +16

Ifosfamide and Doxorubicin in the Treatment of Advanced Leiomyosarcomas of the Uterus: A Gynecologic Oncology Group Study

Gregory P. Sutton, John A. Blessing, John H. Malfetano · Gynecologic Oncology · 1996 · 212 citations

Tumoral Pathology, Gynecological Surgery, Medicine +5